Search results
Biogen Inc. (NASDAQ:BIIB) Stock Position Trimmed by Stephens Inc. AR
ETF DAILY NEWS· 5 days agoStephens Inc. AR cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent ...
Gabelli Funds LLC Has $3.80 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoGabelli Funds LLC trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% during the fourth quarter, according to its most recent ...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 4 days agoDo you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoNEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc ...
Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) -...
Morningstar· 6 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Morningstar· 3 days agoThe Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Biogen
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Crossmark Global Holdings Inc.
ETF DAILY NEWS· 6 days agoCrossmark Global Holdings Inc. decreased its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 19.1% during the 4th quarter, HoldingsChannel ...
...Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with...
Benzinga· 7 days agoThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biogen Inc. ("Biogen ...
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application...
Morningstar· 4 days agoTOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: ...
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Zacks via Yahoo Finance· 4 days agoFDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of...